Impact of strict IGF1 control on quality-of-life scores in patients with acromegaly
ObjectiveExamine, in a real-world setting, whether strict normalization of modestly elevated insulin-like growth factor 1 (IGF1) results in clinical and health-related quality of life benefits in patients with acromegaly using an open-label, non-randomized, 6-month prospective interventional study.M...
Saved in:
Main Authors: | Chaitanya Gandhi, Marie-Claire Denis, Daniel Holmes, Juan Rivera, Stan van Uum, Shereen Ezzat, Constance Chik |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1516899/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and biochemical characteristics of patients with acromegaly and normal or increased prolactin levels
by: Yuliya A. Kukushkina, et al.
Published: (2024-12-01) -
The effect of acromegaly on thyroid disease
by: Caiyan Mo, et al.
Published: (2023-11-01) -
Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients
by: Mehmet Muhittin Yalçın, et al.
Published: (2024-10-01) -
Acromegaly: Is earlier diagnosis possible? Exploration of a screening algorithm to select high-risk patients
by: Tessa N.A. Slagboom, et al.
Published: (2025-03-01) -
Differential diagnosis of rheumatic manifestations of acromegaly. Case report
by: Margarita A. Perepelova, et al.
Published: (2024-12-01)